4.8 Article

Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses

Journal

CELL REPORTS
Volume 9, Issue 5, Pages 1856-1870

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2014.10.067

Keywords

-

Categories

Funding

  1. Cancer Research Institute (CLIP award)
  2. Ludwig Institute for Cancer Research
  3. Alliance for Lupus Research
  4. Melanoma Research Alliance
  5. Bill and Melinda Gates Foundation
  6. American Cancer Society
  7. NIH [R01 AI071078, CCSG 5 P30 CA16087, R37 AI048638, R37 DK057665, U19 AI057266, U19 AI090023]
  8. NIH/NIAMS [5K99AR062595]

Ask authors/readers for more resources

Matrix metalloproteinase-2 (MMP-2) is involved in several physiological mechanisms, including wound healing and tumor progression. We show that MMP-2 directly stimulates dendritic cells (DCs) to both upregulate OX40L on the cell surface and secrete inflammatory cytokines. The mechanism underlying DC activation includes physical association with Toll-like receptor-2 (TLR2), leading to NF-kappa B activation, OX40L upregulation on DCs, and ensuing TH2 differentiation. Significantly, MMP-2 polarizes T cells toward type 2 responses in vivo, in a TLR2-dependent manner. MMP-2-dependent type 2 polarization may represent a key immune regulatory mechanism for protection against a broad array of disorders, such as inflammatory, infectious, and autoimmune diseases, which can be hijacked by tumors to evade immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available